Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.
Cohance Lifesciences Ltd soared 14.81% to Rs 466.4 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 12.57 lakh shares were traded on the counter so far as against the average daily volumes of 64696 shares in the past one month.
Piramal Pharma Ltd spiked 8.26% to Rs 171.75. The stock was the second biggest gainer in 'A' group. On the BSE, 24.21 lakh shares were traded on the counter so far as against the average daily volumes of 3.48 lakh shares in the past one month.
Jain Irrigation Systems Ltd surged 6.44% to Rs 37.5. The stock was the third biggest gainer in 'A' group. On the BSE, 7.85 lakh shares were traded on the counter so far as against the average daily volumes of 2.62 lakh shares in the past one month.
Aarti Pharmalabs Ltd exploded 6.02% to Rs 718.1. The stock was the fourth biggest gainer in 'A' group. On the BSE, 60419 shares were traded on the counter so far as against the average daily volumes of 12632 shares in the past one month.
BASF India Ltd added 5.81% to Rs 3780.4. The stock was the fifth biggest gainer in 'A' group. On the BSE, 5862 shares were traded on the counter so far as against the average daily volumes of 1636 shares in the past one month.
Piramal Pharma Ltd, Kirloskar Oil Engines Ltd, Vedanta Ltd, Neuland Laboratories Ltd are among the other stocks to see a surge in volumes on NSE today, 23 June 2026.
Cohance Lifesciences Ltd registered volume of 234.51 lakh shares by 14:14 IST on NSE, a 41.19 fold spurt over two-week average daily volume of 5.69 lakh shares. The stock rose 13.55% to Rs.460.15. Volumes stood at 3.61 lakh shares in the last session.
Piramal Pharma Ltd saw volume of 811.88 lakh shares by 14:14 IST on NSE, a 25.97 fold spurt over two-week average daily volume of 31.26 lakh shares. The stock increased 6.43% to Rs.168.70. Volumes stood at 27.1 lakh shares in the last session.
Kirloskar Oil Engines Ltd saw volume of 112.23 lakh shares by 14:14 IST on NSE, a 24.16 fold spurt over two-week average daily volume of 4.64 lakh shares. The stock increased 3.75% to Rs.2,479.30. Volumes stood at 17.94 lakh shares in the last session.
Vedanta Ltd saw volume of 1586.3 lakh shares by 14:14 IST on NSE, a 8.78 fold spurt over two-week average daily volume of 180.69 lakh shares. The stock dropped 8.34% to Rs.280.35. Volumes stood at 135.51 lakh shares in the last session.
Neuland Laboratories Ltd recorded volume of 1.69 lakh shares by 14:14 IST on NSE, a 5.6 times surge over two-week average daily volume of 30124 shares. The stock gained 5.25% to Rs.18,128.00. Volumes stood at 16943 shares in the last session.
Piramal Pharma Ltd, ICICI Prudential Life Insurance Company Ltd, New India Assurance Company Ltd, Leela Palaces Hotels & Resorts Ltd are among the other stocks to see a surge in volumes on BSE today, 19 June 2026.
Blue Star Ltd notched up volume of 5.61 lakh shares by 10:47 IST on BSE, a 13.52 fold spurt over two-week average daily volume of 41527 shares. The stock slipped 1.44% to Rs.1,681.10. Volumes stood at 12724 shares in the last session.
Piramal Pharma Ltd notched up volume of 21.44 lakh shares by 10:47 IST on BSE, a 9.41 fold spurt over two-week average daily volume of 2.28 lakh shares. The stock rose 0.72% to Rs.161.35. Volumes stood at 2.38 lakh shares in the last session.
ICICI Prudential Life Insurance Company Ltd registered volume of 5.19 lakh shares by 10:47 IST on BSE, a 6.08 fold spurt over two-week average daily volume of 85327 shares. The stock slipped 1.19% to Rs.515.70. Volumes stood at 1.12 lakh shares in the last session.
New India Assurance Company Ltd saw volume of 15.26 lakh shares by 10:47 IST on BSE, a 4.19 fold spurt over two-week average daily volume of 3.64 lakh shares. The stock increased 5.53% to Rs.188.80. Volumes stood at 26.36 lakh shares in the last session.
Leela Palaces Hotels & Resorts Ltd registered volume of 1.02 lakh shares by 10:47 IST on BSE, a 3.8 fold spurt over two-week average daily volume of 26913 shares. The stock rose 5.52% to Rs.482.95. Volumes stood at 16502 shares in the last session.
Piramal Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 165.7, down 3.04% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.36% on the day, quoting at 23467.1. The Sensex is at 74624.13, up 0.48%.Piramal Pharma Ltd has gained around 3.37% in last one month.Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has increased around 1.87% in last one month and is currently quoting at 24214.25, down 1.23% on the day. The volume in the stock stood at 15.47 lakh shares today, compared to the daily average of 61.33 lakh shares in last one month.
The PE of the stock is 29.36 based on TTM earnings ending March 26.
In a regulatory filing made on Sunday, the company stated that the US FDA had conducted a good manufacturing practices (GMP) inspection of Piramal Pharma’s facility at Sellersville, USA, from 4th May 2026 to 8th May 2026.
At the conclusion of the inspection, US FDA issued a Form-483, with three observations.
At the closing meeting observations were recommended to be classified under VAI (voluntary action indicated) by inspectors. None of the observation relate to data integrity.
'The company is preparing a detailed response to the observations, which will be submitted to the US FDA within the stipulated timelines,' Piramal Pharma said in a statement.
Piramal Pharma offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries.
The company a consolidated net loss of Rs 8.83 crore in the quarter ended March 2026 as against net profit of Rs 153.50 crore during the previous quarter ended March 2025. Sales declined 0.08% to Rs 2,751.77 crore in Q4 FY26 as compared with Q4 FY25.
The scrip shed 0.72% to currently trade at Rs 178.45 on the BSE.
For the full year,net loss reported to Rs 325.94 crore in the year ended March 2026 as against net profit of Rs 91.13 crore during the previous year ended March 2025. Sales declined 3.08% to Rs 8869.08 crore in the year ended March 2026 as against Rs 9151.18 crore during the previous year ended March 2025.
Piramal Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 168.78, up 2% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.74% on the day, quoting at 24075.7. The Sensex is at 77243.68, up 0.76%. Piramal Pharma Ltd has added around 23.61% in last one month.
Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has added around 4.1% in last one month and is currently quoting at 22580.1, up 2.49% on the day. The volume in the stock stood at 68.33 lakh shares today, compared to the daily average of 61.68 lakh shares in last one month.
The benchmark April futures contract for the stock is quoting at Rs 169.6, up 2.1% on the day. Piramal Pharma Ltd is down 21.43% in last one year as compared to a 1.04% fall in NIFTY and a 5.64% fall in the Nifty Pharma index.
The PE of the stock is 29.81 based on TTM earnings ending December 25.
Piramal Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 163.99, up 6.62% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.75% on the day, quoting at 24195.15. The Sensex is at 77763.49, down 0.96%. Piramal Pharma Ltd has added around 20.51% in last one month.
Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has added around 3.23% in last one month and is currently quoting at 22455.45, up 2.24% on the day. The volume in the stock stood at 422.04 lakh shares today, compared to the daily average of 30.77 lakh shares in last one month.
The benchmark April futures contract for the stock is quoting at Rs 162.77, up 6.78% on the day. Piramal Pharma Ltd is down 25.42% in last one year as compared to a 0.21% fall in NIFTY and a 4.48% fall in the Nifty Pharma index.
The PE of the stock is 27.73 based on TTM earnings ending December 25.